Maxeran
Wyeth, the manufacturer of the drug Maxeran, was recently forced by the U.S. Food and Drug Administration to add a black box warning to the heartburn drug after the drug’s use was tied to muscle spasms.
Maxeran, known generically as metoclopramide, speeds up stomach muscle movement so that the contents are more quickly emptied into the intestines. It is used to treat gastroesophageal reflux disease and diabetic gastroparesis.
Maxeran has been linked to tardive dyskenesia a condition with symptoms such as involuntary, repetitive movement of the extremities, lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips or impaired finger movement.
The condition is rarely reversible and there is no known treatment.
The FDA announced the black box warning, the strongest available, on Feb. 26. The heartburn drug is sold to approximately two million Americans in a variety of forms including Maxeran Tablets, Maxeran Oral Disintegrating Tablets, Metoclopramide Oral Solution and Maxeran injection.
If you or a loved one has suffered muscle spasms linked to the heartburn drug, contact The Montgomery Law Firm, LLC